This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Cramer's 'Mad Money' Recap: China and U.S. Stocks

Siegall added that for T-cell lymphoma, the current four-drug cocktail offers patients a 45% remission rate, but by replacing just one of those drugs with one of Seattle Genetics', the remission rate has jumped to 88%. Additionally, Siegall noted that by removing one of the more toxic drugs from the mix, patients are gaining additional benefits from fewer side effects.

Siegall also spoke about the importance of his company's many partnerships. He said Seattle Genetics currently has 12 such agreements, where the company shares technology with other companies in return for revenue, milestones and royalties down the road.

Cramer called Seattle Genetics one of the year's biggest winners and shares are not done heading higher.

Executive Decision: Manny Chirico

In his second "Executive Decision" segment, Cramer sat down with Manny Chirico, chairman and CEO of PVH Corp (PVH), the apparel maker that offered tepid guidance for the rest of 2013, yet has seen its shares rise 19% since Cramer last checked in with the company on June 12.

Chirico explained that despite a strong performance in the quarter, he's seeing volatility from the global consumer and is no longer as bullish as he once was. He said PVH continues to try and understand the consumer better, but so far this quarter the company expected sales to be more robust.

Chirico clarified by indicating that PVH still expects to see a strong fourth quarter for the holiday season, but the back-to-school season thus far included a weak July, a strong August and a soft September thus far, so it remains a challenging environment. Another challenge for the company: Europe, specifically southern Europe, including Italy and Spain, two big markets for PVH. Chirico said that while things in the northern countries have been improving, Italy and Spain remain difficult and are not recovering as quickly.

Other challenges for PVH included the Calvin Klein jeans business, where Chirico said the company will be making big investments to regain lost market share. The turnaround in this segment of the business may take 12 to 24 months to complete, Chirico indicated, but he remains confident the distribution and other elements can be cleaned up for big gains later on.

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs